<< UBC acquires Cognitive Drug Research | Study in Asia finds monkey malaria strain more widespread in humans than previously thought >>

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | עִבְרִית | हिन्दी | Русский | Svenska | Polski

Reportlinker's report on anti-obesity drugs

Published on September 11, 2009 at 12:57 AM · 1 Comment

Reportlinker.com announces that a new market research report is available in its catalogue.

World Anti-Obesity Drugs Market

http://www.reportlinker.com/p0109903/World-Anti-Obesity-Drugs-Market.html

This report analyzes the worldwide markets for Anti-Obesity Drugs in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2005 through 2015.

The report profiles 85 companies including many key and niche players worldwide such as Abbott Laboratories, Alizyme Plc, Amylin Pharmaceuticals, Inc., AstraZeneca Plc., F.HOFFMANN-LA ROCHE LTD., GlaxoSmithKline Plc, Sanofi-Aventis SA, SuperGen, Inc., Takeda Pharmaceutical Company Limited, and VIVUS, Inc.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Source: http://www.reportlinker.com

69f45425-3cbc-4db3-b169-ab3ef34f8761|0|.0

Posted in: Pharmaceutical News

Tags: Bariatric Surgery, Cardiology, Diabetes, Diet, Endocrinology, Exercise, Leptin, Neurology, Obesity, Obstetrics, Pfizer, Phentermine, Pregnancy, Psychiatry, Serotonin, Vaccine, Weight Loss

Related posts

Convergence commences CNV2197944 multiple ascending dose Phase I study for chronic painConvergence Pharmaceuticals Limited, the company focused on the development of novel and high value ...
ERWW PR forms Health Buzz GroupEuro RSCG Worldwide PR (ERWW PR) announces the formation of its Health Buzz Group, a global division...
Needle-free nanopatch vaccine delivery systemThe needle-free nanopatch vaccine delivery system is coming soon after a consortium of investors put...
New data from Zafgen's ZGN-433 Phase 1b study on obesity presented at ADA 2011Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain...
‘Sleeping sickness’ pandemic offers insight into Parkinson’sA bizarre disease that caused sufferers to fall into a deep ‘sleep’ while still being aware of their...
Patients with malignant gastrointestinal disease show high prevalence of malnutritionMalnutrition is an important factor, influencing both morbidity and recovery after surgery. The earl...
Positive clinical trial results of EndoBarrier Gastrointestinal Liner device announcedGI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today ...
Fc engineering enhances antibody half-lifeA Nature Biotechnology article published online January 17 reveals that Xencor Inc.’s proprietary Fc...
Study shows increasing number of U.S. adults are taking antidepressants and antipsychotic medicationsAn increasing number of U.S. adults are being prescribed combinations of antidepressants and antipsy...
Type 1 diabetes youth have abnormal insulin resistance that may increase risk of cardiovascular diseaseAccording to a new study accepted for publication in The Endocrine Society's Journal of Clinical End...
VIVUS to present data on Qnexa at The Obesity Society meetingVIVUS, Inc. today announced that data on Qnexa(TM), an investigational new drug, will be presented a...
Vitamin E during pregnancy puts babies at risk of heart defectsNew research by scientists in the Netherlands has found that vitamin E supplements taken during preg...
Carrying extra weight earlier in life increases risk of physical disabilities adulthoodCarrying extra weight earlier in life increases the risk of developing problems with mobility in old...
Economic development linked to differences in rates of asthma symptomsChildren with allergic sensitizations in economically developed countries are much more likely to de...
Dramatic increase in Caesarean sectionsThe report, published in the prestigious international journal, the British Journal of Obstetrics an...
Menopausal women don't get enough guidance on treatment optionsFew women are consulting their doctors before opting to use herbal therapies and soy products to tre...
Don't kid yourself - puppyfat won't just go awayAccording to the latest research the notion that 'puppy fat' in children disappears as they progress...

Comments

Supposed weight-loss drugs!

Jessica says:

November 22, 2009 at 11:44 AM

My husband was put on a course of these supposed weight-loss drugs, and his life has been horribly awful ever since. I am totally against these sorts of drugs, they are unsafe and potentially catastrophic.

Reply »

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.